Skip to main content
Premium Trial:

Request an Annual Quote

Smith & Nephew: Roland Diggelmann

Smith & Nephew announced Roland Diggelmann will become the company's CEO, effective Nov. 1. He replaces Namal Nawana who is leaving the firm to pursue opportunities outside the UK. Diggelmann has been on Smith & Nephew's board as a non-executive director since March 2018. He spent 11 years at Roche. Before that, he was in strategy and leadership roles at Sulzer Orthopedics and Zimmer, now Zimmer Biomet. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.